Live Breaking News & Updates on Chronic Heart Failure|Page 7
Stay updated with breaking news from Chronic heart failure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investigators found that diastolic pressure gradient and SVO2 can be used for risk prediction in patients with pulmonary hypertension due to left heart disease. ....
Alexion, AstraZeneca’s Rare Disease group, has closed an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal antibody currently in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), an underdiagnosed, systemic . ....
Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition ....